Clinical Trial Update: Extremely Hypofractionated Intensity Modulated Stereotactic Body Radiotherapy for the Treatment of Prostate Cancer With Rising PSA After Radical Prostatectomy [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating extremely hypofractionated intensity-modulated radiotherapy for prostate cancer with rising PSA after radical prostatectomy, c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Snippet

Sponsor: Jonsson Comprehensive Cancer Center | Conditions: Prostate Adenocarcinoma, Stage IIIB Prostate Cancer American Joint Committee on Cancer (AJCC) v8 | Phase 2 | Status: RECRUITING